Skip to main content

Table 4 Contingency table of loLAP or hiLOP scores and disease activity at week 24

From: A combination of cellular biomarkers predicts failure to respond to rituximab in rheumatoid arthritis: a 24-week observational study

 

loLAP

hiLOP

 

DAS28 ≤ 3.2

14

1

Sensitivity: 93.3 %

DAS28 > 3.2

16

13

Specificity: 44.8 %

 

PPV: 46.7 %

NPV: 92.9 %

 
  1. hiLOP high number of total lymphocyte count or plasmablasts, loLAP low number of total lymphocyte count and plasmablasts, DAS28 disease activity score in 28 joints; PPV positive predictive value, NPV negative predictive value